Al-Mehdi- Rx of diabetes and hypoglycemia Flashcards
treatment of type 1 diabetes
insulin
_____combination regimen is the most common insulin regimen
basal + bolus
Long- and ultra-long-acting insulin
basal insulin
Rapid- and intermediate-acting insulin
bolus insulin
what kind of insulin for DKA and HHS
regular insulin
LISPRO
ASPART
GLULISINE
(w/ 5-10 min onset)
bolus insulin
NPH (neutral protamine Hagedorn) w/ 2 hr onset
bolus insulin
regular insulin
(onset 30-60min)
short acting insulin
DETEMIR (2 hr onset)
GLARGINE U100 (2 hr onset)
GLARGINE U300 (6 hr onset)
basal insulin
DEGLUDEC
(1-4 hr onset)
basal insulin
most common and serious side effect of insulin drugs
hypoglycemia
Injection or infusion site rotation is necessary to avoid ______, subcutaneous fat accumulation
lipohypertrophy
All hormones, except sex hormones, are enemies of _____
insulin
new drug w/ moa of anti CD3 on T-cells; and used to treat T1DM
TEPLIZUMAB
β-cell peptide amylin analog used to treat type 1 DM
PRAMLINTIDE
LIRAGLUTIDE (for type 1 DM)
GLP-1R agonist
SOTAGLIFOZIN (for typ1 2 diabetes_
SGLT inhibitor (SE: DKA)
another noninsulin way to treat type 1 diabetes
pancreas and islet transplantation
an elevated C-peptide can have what effects (hopefully a drug will be made with this ability to treat T1DM
decreases A1C, retinopathy, nephropathy, hypoglycemia
how does T2DM start most of the time
as metabolic syndrome (overweight)
very highly effective drug class for goal of weight loss in T2DM
GLP-1RA
SEMAGLUTIDE
TIRZEPATIDE
GLP-1RA used to treat weight loss in T2DM
first line drug for prediabetes and diabetes
Metformin
very highly effective drug class for goal of glycemic control in T2DM
GLP-1RA
SEMAGLUTIDE
TIRZEPATIDE
DULAGLUTIDE
GLP-1RA used to treat type 2 DM
for T2DM patients who have existing atherosclerotic cardiovascular disease /MI/stroke or be at high risk—–what to treat with
GLP-1RA or SGLT2i
for T2DM patients who have existing atherosclerotic cardiovascular disease /MI/stroke or be at high risk, and if A1C is still above goal measurement after trying single drug, what to use
GLP-1RA and SGLT2i
what to treat T2DM patients with existing heart failure
SGLT2i
what to treat T2DM patient with chronic kidney disease
ARBs; SGLT2i
how to treat T2DM patient with cirrhosis
insulin
(new drug) one SQ injection weekly; insulin for T2DM
Insulin Epsitora
what to do next
start basal insulin then progress to basal-bolus
function of enteroendocrine cell w/ its taste receptors
release GLP-1
incretin (GLP-1) increases ____
insulin